{"database": "openregs", "table": "documents", "rows": [["FDA-2023-N-5160-0011", "FDA", "FDA-2023-N-5160", "Labeling Requirements for Approved or Conditionally Approved New Animal Drugs; Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2024-05-22T04:00:00Z", 2024, 5, "2024-05-22T04:00:00Z", null, "2024-05-22T15:13:20Z", "2024-11229", 0, 0, "0900006486579492"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2023-N-5160-0011"], "units": {}, "query_ms": 0.47905207611620426, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}